Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New technology could improve clinical trial recruitment

25.10.2005


Electronic medical records are touted as a great way to prevent medical errors, but researchers are reporting that this new technology may also be just what the doctor ordered for clinical trial recruitment.



A new study led by Peter Embi, MD, assistant professor of medicine at the University of Cincinnati (UC) and researcher at UC’s Institute for the Study of Health, shows that by using the tools of an electronic medical record system in a new way, it’s possible to increase the number of patients who volunteer to participate in clinical studies and generate more referrals from the physician community.

The research, conducted in large part at the Cleveland Clinic, appears in the Oct. 24, 2005, edition of the Archives of Internal Medicine.


"The success of clinical trials depends on the timely recruitment of enough eligible subjects," said Dr. Embi. "Researchers spend a lot of time and effort trying to find subjects for their studies, but most traditional recruitment methods aren’t very effective."

Even in fields like oncology, where clinical trial enrollment for all eligible patients is considered the goal, as few as 2 percent of patients participate, the report says.

"We wanted to find another way to increase study recruitment across the board, using technology that will soon make its way into many outpatient clinics," said Dr. Embi.

Dr. Embi and his team carefully monitored a full year of traditional recruitment (fliers, word of mouth and memorandums) for a trial of patients with type 2 diabetes. At the end of the year, they activated what they call a Clinical Trial Alert (CTA) system.

After the CTA was activated, Dr. Embi’s team noticed an eight-fold increase in the number of physicians referring patients to the trial, and 10 times the number of patients actually referred per month. This increase resulted in a doubling of the study enrollment rate from physician referrals for the specific diabetes trial they were monitoring.

The CTA system works by scanning the information a physician keys into a patient’s electronic chart. As the physician talks with patients about their medical history and enters information, the CTA system searches for key data that match up with current clinical trials.

If a patient matches a critical portion of a trial’s eligibility requirements, the CTA sends an alert--like a pop-up--to the screen of the patient’s electronic medical record.

The physician is reminded about the study and can then ask if the patient is interested in being considered for it. If the patient agrees, the physician simply clicks a button to send a message to the study coordinator, who will take it from there. All of this happens within the secure environment of the electronic medical record.

"It’s often difficult during a busy office visit to remember what clinical trials are available for your patient, much less find the time to determine whether your patient is actually eligible, discuss the trial and then refer the patient on for possible enrollment," said Dr. Embi. "By leveraging the electronic medical record’s capabilities, the CTA made the recruitment process easier and helped many more physicians offer their patients the opportunity to participate in the trial."

Dr. Embi plans to continue research on the CTA system and clinical trial recruitment at the University of Cincinnati and UC Physicians, a multi-specialty practice made up of over 500 University of Cincinnati faculty.

Additional authors include Richard Hornung, DrPH, University of Cincinnati, and Anil Jain, MD, Jeffrey Clark, Susan Bizjack and C. Martin Harris, MD, all of the Cleveland Clinic Foundation.

Dama Kimmon | EurekAlert!
Further information:
http://www.uc.edu

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>